Chardan to Facilitate Nocturne Acquisition Corporation’s Business Combination with Cognos Therapeutics Inc., Paving the Way for NASDAQ Listing
Chardan Engaged to Facilitate Nocturne Acquisition Corporation’s Business Combination with Cognos Therapeutics WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (“Nocturne”) and Cognos Therapeutics, Inc. (“Cognos”) have made a significant announcement today with the engagement of Chardan, a leading global investment bank, in the role of capital…